Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

This study has been completed.
Sponsor:
Information provided by:
UCB Pharma
ClinicalTrials.gov Identifier:
NCT00630630
First received: February 27, 2008
Last updated: November 25, 2013
Last verified: September 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2003
  Primary Completion Date: November 2003 (Final data collection date for primary outcome measure)